ACTINIUM PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Assets
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Gain (Loss) on Disposition of Assets of -$554.31 thousand for the 166-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2016-03-11
- ACTINIUM PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2013-12-31 was $0.00.
- ACTINIUM PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2013-09-30 was $0.00.
- ACTINIUM PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2013-06-30 was $0.00.
- ACTINIUM PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2013-03-31 was -$4.12K.
- ACTINIUM PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2013 was -$4.12K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 157 month | Gain (Loss) on Disposition of Assets 160 month | Gain (Loss) on Disposition of Assets 163 month | Gain (Loss) on Disposition of Assets 166 month |
|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | -$554.31K 10-Q · filed 2014-05-12 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-11 | -$4.12K 10-K · filed 2016-03-11 | -$554.31K 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $0.00 derived: sum of 2 quarters · filed 2014-10-31 | -$4.12K 10-Q · filed 2014-10-31 | -$554.31K 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$4.12K 10-Q · filed 2014-08-12 | -$554.31K 10-Q · filed 2013-08-13 | |||||
| 2013-03-31 | -$4.12K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |